Article: FDA Approves Revolutionary Cochlear Implant System

Nucleus 24 Cochlear Implant and ESPrit Ear Level Speech Processor

Now Available For Severe-To-Profoundly Deaf Adults And Children

DENVER, June 26 /PRNewswire/ -- The Food and Drug Administration (FDA) today released the Nucleus(R) 24 Channel Cochlear Implant and the ESPrit(TM) Ear Level Speech Processor for use in severe-to-profoundly deaf adults and profoundly deaf children as young as age 18 months. This is the first true advance in cochlear implant technology in more than a decade, and one that combines the most sophisticated technology with the simplest, most cosmetically discreet external device available.

Among its many ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!